Quick Answer
Celularity Inc reported Total Revenue of $54.22 million for fiscal year 2024.
Celularity Inc — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $54.22M +138.1% |
$22.77M +26.7% |
$17.98M -15.7% |
$21.34M +49.4% |
$14.28M | — |
| Revenue (ASC 606) | $54.22M +138.1% |
$22.77M +26.7% |
$17.98M -15.7% |
$21.34M +49.4% |
$14.28M | — |
| Net Income | -$57.89M +70.5% |
-$196.29M -1483.1% |
$14.19M +114.2% |
-$100.12M +51.9% |
-$208.23M -8386.3% |
$2.51M |
| Diluted EPS | -$2.64 +76.0% |
-$11.02 -1260.0% |
$0.95 +163.8% |
-$1.49 | — | — |
| Total Assets | $132.68M -7.8% |
$143.89M -64.1% |
$401.07M -3.2% |
$414.13M -3.9% |
$431.01M +47.8% |
$291.61M +167050.3% |
| Cash and Equivalents | $738.0K +225.1% |
$227.0K -98.4% |
$13.97M -62.5% |
$37.24M -31.4% |
$54.31M +5822.6% |
$917.0K +3611.5% |
| Stockholders Equity | $8.84M -78.4% |
$40.96M -79.4% |
$198.90M +100.1% |
$99.42M +118.7% |
-$531.40M -62.3% |
-$327.42M -1369943.5% |
| R&D Expense | $17.39M -42.9% |
$30.46M -61.1% |
$78.36M -11.3% |
$88.35M +67.6% |
$52.71M | — |
| Operating Income | -$38.36M +80.1% |
-$192.29M -651.1% |
-$25.60M +76.5% |
-$109.06M +28.2% |
-$151.93M -26820.9% |
-$564.3K |
| Shares Outstanding | 22.55M +16.4% |
19.38M +30.1% |
14.89M -88.0% |
124.31M +570.9% |
18.53M | — |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $5.28M | -43.2% | -7.9% |
| Revenue (ASC 606) | September 30, 2025 | $5.28M | -43.2% | -7.9% |
| Net Income | September 30, 2025 | -$23.08M | -43.3% | +5.9% |
| Diluted EPS | September 30, 2025 | -$0.88 | -20.5% | +13.7% |
| Total Assets | September 30, 2025 | $114.24M | -11.3% | -5.0% |
| Cash and Equivalents | September 30, 2025 | $120.0K | -9.8% | -86.1% |
| Long-Term Debt | June 30, 2023 | $17.03M | — | +258.8% |
| Stockholders Equity | September 30, 2025 | -$20.09M | -216.3% | +21.2% |
| R&D Expense | September 30, 2025 | $4.60M | +17.4% | +37.2% |
| Operating Income | September 30, 2025 | -$12.90M | -11.9% | +18.7% |
| Shares Outstanding | September 30, 2025 | 28.22M | +28.3% | +14.7% |
- Celularity Inc reported Total Revenue of $54.22 million for fiscal year 2024.
- Celularity Inc showed an increase of +138.1% in Total Revenue compared to the prior fiscal year.
- Celularity Inc reported Revenue (ASC 606) of $54.22 million for fiscal year 2024.
- Celularity Inc showed an increase of +138.1% in Revenue (ASC 606) compared to the prior fiscal year.
- Celularity Inc reported Net Income of -$57.89 million for fiscal year 2024.
- Celularity Inc showed an increase of +70.5% in Net Income compared to the prior fiscal year.
- Celularity Inc reported Diluted EPS of $2.64 per share (loss) for fiscal year 2024.
- Celularity Inc showed an increase of +76.0% in Diluted EPS compared to the prior fiscal year.
- Celularity Inc reported Total Assets of $132.68 million for fiscal year 2024.
- Celularity Inc showed a decrease of -7.8% in Total Assets compared to the prior fiscal year.
- Celularity Inc reported Cash and Equivalents of $738.0 thousand for fiscal year 2024.
- Celularity Inc showed an increase of +225.1% in Cash and Equivalents compared to the prior fiscal year.
- Celularity Inc reported Stockholders Equity of $8.84 million for fiscal year 2024.
- Celularity Inc showed a decrease of -78.4% in Stockholders Equity compared to the prior fiscal year.
- Celularity Inc reported R&D Expense of $17.39 million for fiscal year 2024.
- Celularity Inc showed a decrease of -42.9% in R&D Expense compared to the prior fiscal year.
- Celularity Inc reported Operating Income of -$38.36 million for fiscal year 2024.
- Celularity Inc showed an increase of +80.1% in Operating Income compared to the prior fiscal year.
- Celularity Inc reported Shares Outstanding of 22.55 million shares for fiscal year 2024.
- Celularity Inc showed an increase of +16.4% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: